Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Perilli et al. Early Diagnostic Markers in Crisponi Syndrome: Two Cases and Review. <i>J. Clin. Med.</i> 2025, <i>14</i>, 7757.

Journal of clinical medicine·2026
Same author

Early Diagnostic Markers in Crisponi Syndrome: Two Cases and Review.

Journal of clinical medicine·2025
Same author

Developmental and epileptic encephalopathies: From current care to future perspectives - insights from epilepsy centres in Lombardy, Italy.

Epilepsy & behavior : E&B·2025
Same author

Italian report on RARE epilepsies (i-RARE): A consensus on multidisciplinarity.

Epilepsia open·2024
Same author

Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity.

American journal of human genetics·2024
Same author

Best practices for the management of febrile seizures in children.

Italian journal of pediatrics·2024
Same journal

Responsible use of artificial intelligence in peer-reviewed publications in epilepsy.

Epilepsia·2026
Same journal

Altered autonomic balance drives the increase in cardiac output and arterial pressure during convulsive seizures in nonanesthetized sheep.

Epilepsia·2026
Same journal

Diagnostic yield and copy number variants findings in 219 adult patients with developmental and epileptic encephalopathy.

Epilepsia·2026
Same journal

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Epilepsia·2026
Same journal

Electrocardiography characteristics and long-term mortality in people with epilepsy from a resource-poor community.

Epilepsia·2026
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2026

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation
06:28

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation

Published on: October 31, 2025

Changes in Panayiotopoulos syndrome over time.

Giuseppe Capovilla1, Pasquale Striano, Francesca Beccaria

  • 1Department of Child Neuropsychiatry, Ospedale C. Poma, Mantova, Italy. pippo.capovilla@ospedalimantova.it

Epilepsia
|May 28, 2009
PubMed
Summary
This summary is machine-generated.

Panayiotopoulos syndrome, initially described in 1989, is a benign childhood epilepsy. Its clinical spectrum has expanded beyond occipital lobe seizures, yet diagnostic and genetic aspects remain unclear.

More Related Videos

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Experiment Videos

Last Updated: Jun 22, 2026

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation
06:28

An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation

Published on: October 31, 2025

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Area of Science:

  • Neurology
  • Epileptology
  • Pediatric Neurology

Background:

  • Panayiotopoulos syndrome (PS) was first described in 1989 as an idiopathic epilepsy syndrome.
  • It was characterized by nocturnal seizures, tonic eye deviation, and vomiting, suggesting occipital lobe involvement.
  • The syndrome has since been recognized as a benign, age-related focal epilepsy with an expanding clinical spectrum.

Purpose of the Study:

  • To review the evolution of the understanding of Panayiotopoulos syndrome.
  • To highlight the expanded clinical manifestations beyond the initial description.
  • To identify unresolved issues in the diagnosis, genetics, and pathophysiology of PS.

Main Methods:

  • Literature review and synthesis of existing studies on Panayiotopoulos syndrome.
  • Analysis of clinical, electroencephalographic, and genetic data from reported cases.
  • Discussion of theoretical and practical challenges in PS management.

Main Results:

  • The clinical spectrum of PS has broadened significantly, encompassing diverse seizure types.
  • While initially linked to occipital lobe epilepsy, PS now includes a wider range of presentations.
  • Prognosis remains generally excellent, consistent with its classification as a benign epilepsy.

Conclusions:

  • Panayiotopoulos syndrome is a recognized benign childhood epilepsy with evolving clinical features.
  • Further research is needed to address unresolved diagnostic, genetic, and pathophysiological questions.
  • Clarifying these aspects will improve the understanding and management of this common epilepsy syndrome.